Finally, the Intracellular Signaling Protein Panel found very low HER2 protein, when comparing relative level of Study biopsy #2-derived protein expression compared to two cohorts of metastatic breast cancers: all subtypes (BC) and TNBC (Fig. 3, HER2 box plot under “Receptor”). This evidence concerns the gene ERBB2 and breast cancer.